Literature DB >> 17055783

Outcomes of IVF conceptions: are they different?

Jane Halliday1.   

Abstract

Perinatal outcomes, such as preterm delivery, low birth weight and some obstetric complications, are increased significantly after in-vitro fertilization (IVF) compared with spontaneously conceived pregnancies. The degree of difference is greater for singletons than for twins, especially with regard to preterm delivery which is increased two fold in IVF singletons and by 40% in twins. It is difficult to obtain accurate outcome information because of unmeasured confounders such as smoking status and fetal reduction. It is also unknown whether IVF technologies or patient infertility is the major contributor to adverse outcomes. Birth defects are increased, shown in a number of systematic reviews, and there has been a particular interest in imprinting syndromes. Epigenetic modifications may play a larger role in IVF outcomes, as yet unidentified. There is no apparent increase in adverse outcomes in children up to adolescence, although further studies are needed to examine longer-term risks, including those for cancer.

Entities:  

Mesh:

Year:  2006        PMID: 17055783     DOI: 10.1016/j.bpobgyn.2006.08.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  13 in total

1.  Genomic imprinting, small babies and assisted reproduction.

Authors:  David J Amor
Journal:  Eur J Hum Genet       Date:  2008-10-22       Impact factor: 4.246

Review 2.  Epigenetically regulated imprinted gene expression associated with IVF and infertility: possible influence of prenatal stress and depression.

Authors:  Julia F Litzky; Carmen J Marsit
Journal:  J Assist Reprod Genet       Date:  2019-05-24       Impact factor: 3.412

Review 3.  Epigenetic changes and assisted reproductive technologies.

Authors:  Sneha Mani; Jayashri Ghosh; Christos Coutifaris; Carmen Sapienza; Monica Mainigi
Journal:  Epigenetics       Date:  2019-07-25       Impact factor: 4.528

4.  Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome.

Authors:  M Yamamoto; S L Feigenbaum; Y Crites; G J Escobar; J Yang; A Ferrara; J C Lo
Journal:  J Perinatol       Date:  2012-01-19       Impact factor: 2.521

5.  The prevalence of chromosomal deletions relating to developmental delay and/or intellectual disability in human euploid blastocysts.

Authors:  Wenyin He; Xiaofang Sun; Lian Liu; Man Li; Hua Jin; Wei-Hua Wang
Journal:  PLoS One       Date:  2014-01-07       Impact factor: 3.240

Review 6.  Strategies to prevent preterm birth.

Authors:  John P Newnham; Jan E Dickinson; Roger J Hart; Craig E Pennell; Catherine A Arrese; Jeffrey A Keelan
Journal:  Front Immunol       Date:  2014-11-19       Impact factor: 7.561

7.  Australian women's use of complementary and alternative medicines to enhance fertility: exploring the experiences of women and practitioners.

Authors:  Jo-Anne Rayner; Helen L McLachlan; Della A Forster; Rhian Cramer
Journal:  BMC Complement Altern Med       Date:  2009-12-15       Impact factor: 3.659

8.  Health and development of ART conceived young adults: a study protocol for the follow-up of a cohort.

Authors:  Cate Wilson; Karin Hammarberg; Fiona Bruinsma; Turi Berg; David Amor; Ann Sanson; Jane R Fisher; Jane Halliday
Journal:  Reprod Health       Date:  2013-03-15       Impact factor: 3.223

9.  Tubal factor infertility and perinatal risk after assisted reproductive technology.

Authors:  Jennifer F Kawwass; Sara Crawford; Dmitry M Kissin; Donna R Session; Sheree Boulet; Denise J Jamieson
Journal:  Obstet Gynecol       Date:  2013-06       Impact factor: 7.623

10.  Mortality and major morbidities in very preterm infants born from assisted conception or naturally conceived: results of the area-based ACTION study.

Authors:  Carlo Corchia; Monica Da Frè; Domenico Di Lallo; Luigi Gagliardi; Franco Macagno; Virgilio Carnielli; Silvana Miniaci; Marina Cuttini
Journal:  BMC Pregnancy Childbirth       Date:  2014-09-05       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.